Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Ionis licenses IONIS-AZ5-2.5Rx to AstraZeneca

Feb. 22, 2018

FDA issues complete response letter for Vitaros

Feb. 19, 2018

Pfizer patents novel C5a1 receptor antagonists

Feb. 16, 2018

Astellas divulges new melanocortin MC4 receptor agonists

Feb. 7, 2018

Cara Therapeutics begins pivotal phase III study of Korsuva in CKD-associated pruritus

Feb. 1, 2018

EMA committee hands down negative opinion for enclomiphene MAA

Jan. 29, 2018

Boehringer Ingelheim identifies novel cytochrome P450 11B2 inhibtors

Jan. 26, 2018

EMA committee gives positive opinion on orphan drug status for OMS-721

Jan. 23, 2018

FDA accepts two IND applications for OP-687

Jan. 18, 2018

FDA advisory committee votes against testosterone replacement therapy Tlando

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...